{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:24:18Z","timestamp":1778804658091,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.leukres.2006.12.024","type":"journal-article","created":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T12:30:58Z","timestamp":1172665858000},"page":"1389-1392","source":"Crossref","is-referenced-by-count":28,"title":["Global cytokine analysis in myeloproliferative disorders"],"prefix":"10.1016","volume":"31","author":[{"given":"Ching-Liang","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terra L.","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph H.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2006.12.024_bib1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4065\/73.12.1177","article-title":"The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview","volume":"73","author":"Tefferi","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.leukres.2006.12.024_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF02981934","article-title":"The pathogenesis of chronic myeloproliferative diseases","volume":"73","author":"Tefferi","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/beha.2001.0153","article-title":"Myeloproliferative disorders","volume":"14","author":"Bench","year":"2001","journal-title":"Bailliere's Best Pract Rev Clin Hematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(01)90133-7","article-title":"Chronic myeloid disorders: classification and treatment overview","volume":"38","author":"Tefferi","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2141.1997.3293146.x","article-title":"The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis","volume":"99","author":"Murate","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.10020","article-title":"Soluble angiogenic factors: implications for chronic myeloproliferative disorders","volume":"69","author":"Musolino","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2141.2002.03874.x","article-title":"Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis","volume":"119","author":"Wang","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/cyto.2002.1994","article-title":"Abnormal production of interleukin (IL)-11 and IL-8 in polycythaemia vera","volume":"20","author":"Hermouet","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.leukres.2006.12.024_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1034\/j.1600-0609.2003.00096.x","article-title":"Elevated plasma levels of TIMP-1 correlate with plasma suPAR\/uPA in patients with chronic myeloproliferative disorders","volume":"71","author":"Jensen","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2006.12.024_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(01)00394-5","article-title":"Detection of multiple proteins in an antibody-based protein microarray system","volume":"255","author":"Huang","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.leukres.2006.12.024_bib12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.0300-9475.2004.01432.x","article-title":"Circulating cytokines in primary Sjogren's syndrome determined by a multiplex cytokine array system","volume":"59","author":"Szodoray","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.leukres.2006.12.024_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/abio.2001.5156","article-title":"Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system","volume":"294","author":"Huang","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1016\/j.leukres.2006.12.024_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/CCLM.2003.023","article-title":"Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate","volume":"41","author":"Lin","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.leukres.2006.12.024_bib15","first-page":"337","article-title":"Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders","volume":"72","author":"Yoon","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2006.12.024_bib16","first-page":"52","article-title":"Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders","volume":"86","author":"Yoon","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2006.12.024_bib17","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1242\/jcs.00063","article-title":"Metalloproteinase inhibitors: biological actions and therapeutic opportunities","volume":"115","author":"Baker","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.leukres.2006.12.024_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0303-7207(01)00489-0","article-title":"Alterations of the insulin-like growth factor system in patients with polycythemia vera","volume":"181","author":"Michl","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.leukres.2006.12.024_bib19","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.V89.6.1862","article-title":"Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation","volume":"89","author":"Mirza","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.12.024_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.12.024_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.leukres.2004.03.009","article-title":"Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders","volume":"28","author":"Bock","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.12.024_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/mgme.1999.2920","article-title":"Novel aspects of the insulin-like growth factor binding proteins","volume":"68","author":"Wetterau","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.leukres.2006.12.024_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.leukres.2006.12.024_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000204320","volume":"91","author":"Titius","year":"1994","journal-title":"Acta Haematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T07:52:22Z","timestamp":1587369142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0145212607000069"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2006.12.024","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}